Matt Galsky, MD, delved into the recent approval of a perioperative durvalumab regimen in muscle-invasive bladder cancer.

The Queen Elizabeth Hospital (QEH) Foundation is celebrating a remarkable donor achievement: the successful completion of the ...

The following is a summary of “Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder, ureterocutaneostomy or ileal conduit: ...

The presence of residual tumor cells in the trigone and urethra after robot-assisted radical cystectomy (RARC) is associated with a higher tumor stage, positive margins, and cancer recurrence compared ...

OVERACTIVE bladder (OAB) affects approximately 12% of adult women. Categorised by urinary urgency and frequency, and nocturia, it significantly impacts quality of life. A recent study examined the ...

Deaths among hospitalized patients with bladder cancer in the United States significantly increased from 4.5% in 2008 to 4.9% in 2021, driven by increased mortality among specific subgroups, ...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that the U.S. Food and Drug ...

Urinary Tract Infections (UTIs) are a significant burden on global health, affecting millions of people each year and ...

Small leaks sinks big ships, if any urine issues are addressed at the earlier stage itself, it can prevent future disasters ...

Urodynamics plus comprehensive clinical assessment (CCA) is not superior to CCA only for women with refractory overactive ...

Clinical guidelines should establish clear timelines, and health care systems should prioritize timely treatment initiation and completion,” researchers concluded.

Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...